Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6411
    -0.0015 (-0.23%)
     
  • OIL

    82.34
    -0.39 (-0.47%)
     
  • GOLD

    2,392.70
    -5.30 (-0.22%)
     
  • Bitcoin AUD

    101,373.23
    +3,473.60 (+3.55%)
     
  • CMC Crypto 200

    1,341.70
    +29.07 (+2.27%)
     
  • AUD/EUR

    0.6016
    -0.0014 (-0.24%)
     
  • AUD/NZD

    1.0892
    +0.0017 (+0.16%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,841.45
    -35.60 (-0.45%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,738.08
    -99.32 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Selectis Health Schedules Third Quarter Earnings Call for Tuesday, November 16, 2021

Greenwood Village, Colorado, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company"), announced today that it expects to issue its third quarter 2021 financial results on November 16, 2021.

Conference Call

Selectis invites current and prospective investors to join the shareholder call on November 16, 2021, at 4:15 PM EST (1:15 PM PST), during which Selectis’ management will discuss the Company’s third quarter 2021 performance.

The number to call for the interactive teleconference is (877)-705-6003 and the confirmation number is 13725159. A telephonic replay of the call will be available after 7:15 PM EST on the same day through Tuesday, November 30, 2021, by dialing (844)-512-2921 and entering the confirmation number 13725159.

ADVERTISEMENT

About Selectis Health

Selectis Health owns and/or operates health care facilities in Arkansas, Georgia, Ohio, and Oklahoma providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services.

For Further Information Contact:
Brandon Thall
investors@selectis.com